Nautilus Biotechnology, Inc. (NAUT) Financials

NAUT Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 305.6 million 40.2 million
2023-09-30 318.3 million 41.1 million
2023-06-30 330.8 million 41.1 million
2023-03-31 345.9 million 42.2 million

NAUT Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -14.3 million 3.1 million
2023-09-30 -12.6 million 3.1 million
2023-06-30 -14.0 million 3.1 million
2023-03-31 -13.2 million 2.9 million

NAUT Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 -17.0 million
2023-09-30 -15.9 million
2023-06-30 -15.8 million
2023-03-31 -15.0 million

NAUT Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 173.4 million - 34.6 million
2023-09-30 183.3 million - 35.6 million
2023-06-30 163.3 million - 36.5 million
2023-03-31 167.3 million - 37.3 million

NAUT Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 125.0 million
2023-09-30 124.9 million
2023-06-30 124.6 million
2023-03-31 124.6 million

NAUT Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 413000 12.5 million 7.5 million -
2023-09-30 874000 12.0 million 7.1 million -
2023-06-30 463000 11.9 million 7.1 million -
2023-03-31 692000 10.9 million 7.2 million -

NAUT Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 1.6 million
2023-09-30 - 1.5 million
2023-06-30 - 1.4 million
2023-03-31 - 1.2 million

NAUT

Price: $2.69

52 week price:
2.16
4.65

Earnings Per Share: -0.51 USD

P/E Ratio: -5.87

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 189600

Market Capitalization: 346.5 million

Links: